Internal Medicine, Medical Oncology · New Haven, CT
NPI
1396726113
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
333 Cedar St, Yale University School of Medicine
New Haven, CT, 06510
Phone (203) 200-4822
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
557 services
Medicare patients, 2024
191
Average age 75
Drug cost, 2024
$6.4M
1,441 prescriptions
Company payments, 2025
$699
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael E Hurwitz was code 99214 (office e&m - established), 337 times for 135 patients. In total Michael E Hurwitz billed 557 services in 14 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 337 | 135 | $74.08 | $25K |
| 99215 Office E&M - Established | Facility | 102 | 54 | $114.18 | $12K |
| 99214 Office E&M - Established | Office | 27 | 19 | $103.37 | $2,791 |
| 99232 Hospital E&M - Subsequent | Facility | 22 | 18 | $64.23 | $1,413 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $106.60 | $1,706 |
| 99204 Office E&M - New | Facility | 15 | 15 | $101.77 | $1,527 |
By year: 2022 $50K for 576 services; 2023 $44K for 535 services; 2024 $48K for 557 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael E Hurwitz prescribed most often to Medicare patients was Prednisone, with 284 prescriptions and refills. In total Michael E Hurwitz wrote 1,441 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 284 | 328 | 56 | $1,067 |
| Abiraterone Acetate Generic | 260 | 281 | 38 | $614K |
| Nubeqa Darolutamide | 150 | 157 | 21 | $2.0M |
| Xtandi Enzalutamide | 79 | 89 | 14 | $1.0M |
| Orgovyx Relugolix | 62 | 69 | 13 | $182K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 49 | 53 | Under 11 | $255 |
| Welireg Belzutifan | 46 | 47 | Under 11 | $1.1M |
| Ondansetron Odt Ondansetron | 33 | 33 | 22 | $835 |
| Bicalutamide Generic | 30 | 30 | 17 | $431 |
| Levothyroxine Sodium Generic | 30 | 38 | Under 11 | $195 |
| Dexamethasone Generic | 26 | 31 | 18 | $377 |
| Prochlorperazine Maleate Generic | 24 | 24 | 17 | $335 |
| Pregabalin Generic | 22 | 22 | Under 11 | $265 |
| Inlyta Axitinib | 20 | 20 | Under 11 | $343K |
| Tamsulosin Hcl Generic | 18 | 48 | Under 11 | $624 |
Brand drugs: 426 claims; generic drugs: 1,015 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael E Hurwitz $699 ($450 in general payments such as food, travel and fees and $249 for research) from 5 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $249.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.